The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy
Author:
- 19 February 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Cardiovascular Therapy
- Vol. 12 (3) , 345-358
Abstract
Cardiomyopathy, the presence of cardiac dysfunction independent of ischemic heart disease and/or hypertension, is becoming a more prominent condition in our diabetic patient population. Unfortunately, we do not yet understand the mechanism(s) responsible for causing diabetic cardiomyopathy. With the recent explosion in the obesity and Type 2 diabetes epidemic, our understanding of dyslipidemia and the adverse effects of lipid surplus on cellular and organ function has grown considerably. Numerous studies now illustrate that excess lipid accumulation may exert direct toxic effects on cellular function, a term coined 'lipotoxicity'. As obesity and Type 2 diabetes are significant risk factors for cardiovascular disease, cardiac lipotoxicity may represent a significant component mediating the diabetic cardiomyopathy phenotype. Therefore, a more complete understanding of how cardiac lipotoxicity is regulated and how different lipid metabolites cause cellular dysfunction may lead to the discovery of novel targets to treat cardiomyopathy in our diabetic patient population.Keywords
This publication has 116 references indexed in Scilit:
- Cholesteryl Esters Accumulate in the Heart in a Porcine Model of Ischemia and ReperfusionPLOS ONE, 2013
- Cardiomyocyte Specific Deficiency of Serine Palmitoyltransferase Subunit 2 Reduces Ceramide but Leads to Cardiac DysfunctionJournal of Biological Chemistry, 2012
- Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin ResistanceCell Metabolism, 2012
- ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1Nature Medicine, 2011
- RETRACTED: Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunctionJournal of Molecular and Cellular Cardiology, 2011
- DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates LipotoxicityJournal of Biological Chemistry, 2009
- Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human HeartJACC, 2009
- Impact of Gender on the Myocardial Metabolic Response to ObesityJACC: Cardiovascular Imaging, 2008
- Continuous fat oxidation in acetyl–CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivityProceedings of the National Academy of Sciences, 2007
- The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndromeProceedings of the National Academy of Sciences, 2007